|
1
|
Martel-Pelletier J, Boileau C, Pelletier
JP and Roughley PJ: Cartilage in normal and osteoarthritis
conditions. Best Pract Res Clin Rheumatol. 22:351–384. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holmborn K, Habicher J, Kasza Z, Eriksson
AS, Filipek-Gorniok B, Gopal S, Couchman JR, Ahlberg PE, Wiweger M,
Spillmann D, et al: On the roles and regulation of chondroitin
sulfate and heparin sulfate in zebrafish pharyngeal cartilage
morphogenesis. J Biol Chem. 287:33905–33916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Winship A, Van Sinderen M, Heffernan-Marks
A and Dimitriadis E: Chondroitin sulfate proteoglycan protein is
stimulated by interleukin 11 and promotes endometrial epithelial
cancer cell proliferation and migration. Int J Oncol. 50:798–804.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
du Souich P, García AG, Vergés J and
Montell E: Immunomodulatory and anti-inflammatory effects of
chondroitin sulphate. J Cell Mol Med. 13:1451–1463. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Alterations of glycosaminoglycan disaccharide content and
composition in colorectal cancer: Structural and expressional
studies. Oncol Rep. 22:369–375. 2009.PubMed/NCBI
|
|
6
|
Ogawa H, Hatano S, Sugiura N, Nagai N,
Sato T, Shimizu K, Kimata K, Narimatsu H and Watanabe H:
Chondroitin sulfate synthase-2 is necessary for chain extension of
chondroitin sulfate but not critical for skeletal development. PLoS
One. 7:e438062012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hashimoto SI, Ogoshi K, Sasaki A, Abe J,
Qu W, Nakatani Y, Ahsan B, Oshima K, Shand FH, Ametani A, et al:
Coordinated changes in DNA methylation in antigen-specific memory
CD4 T cells. J Immunol. 190:4076–4091. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilson DG, Phamluong K, Lin WY, Barck K,
Carano RA, Diehl L, Peterson AS, Martin F and Solloway MJ:
Chondroitin sulfate synthase 1 (Chsy1) is required for bone
development and digit patterning. Dev Biol. 363:413–425. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Laue K, Temtamy S, Aglan M, Kotan
LD, Yigit G, Canan H, Pawlik B, Nürnberg G, Wakeling EL, et al:
Temtamy preaxial brachydactyly syndrome is caused by
loss-of-function mutations in chondroitin synthase 1, a potential
target of BMP signaling. Am J Hum Genet. 87:757–767. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin L: Chondroitin synthase 1 is a key
molecule in myeloma cell-osteoclast interactions. J Biol Chem.
280:15666–15672. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Momose T, Yoshimura Y, Harumiya S, Isobe
K, Kito M, Fukushima M, Kato H and Nakayama J: Chondroitin sulfate
synthase 1 expression is associated with malignant potential of
soft tissue sarcomas with myxoid substance. Hum Pathol. 50:15–23.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian J, Ling L, Shboul M, Lee H, O'Connor
B, Merriman B, Nelson SF, Cool S, Ababneh OH, Al-Hadidy A, et al:
Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic
brachydactyly in humans via increased NOTCH signaling. Am J Hum
Genet. 87:768–778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu CH, Lan CT, Chou JF, Tseng TJ and Liao
WC: CHSY1 promotes aggressive phenotypes of hepatocellular
carcinoma cells via activation of the hedgehog signaling pathway.
Cancer Lett. 403:280–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Chondroitin synthases I, II, III and chondroitin sulfate
glucuronyltransferase expression in colorectal cancer. Mol Med Rep.
4:363–368. 2011.PubMed/NCBI
|
|
15
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pabla B, Bissonnette M and Konda VJ: Colon
cancer and the epidermal growth factor receptor: Current treatment
paradigms, the importance of diet, and the role of chemoprevention.
World J Clin Oncol. 6:133–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase III trial after a median follow-up
of 11 years. J Clin Oncol. 30:1926–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo Y, Tsuchiya KD II, Park D, Fausel R,
Kanngurn S, Welcsh P, Dzieciatkowski S, Wang J and Grady WM: RET is
a potential tumor suppressor gene in colorectal cancer. Oncogene.
32:2037–2047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fisher R, Pusztai L and Swanton C: Cancer
heterogeneity: Implications for targeted therapeutics. Br J Cancer.
108:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xia JT, Chen LZ, Jian WH, Wang KB, Yang
YZ, He WL, He YL, Chen D and Li W: MicroRNA-362 induces cell
proliferation and apoptosis resistance in gastric cancer by
activation of NF-κB signaling. J Transl Med. 12:332014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui H, Yuan J, Du X, Wang M, Yue L and Liu
J: Ethyl gallate suppresses proliferation and invasion in human
breast cancer cells via Akt-NF-κB signaling. Oncol Rep.
33:1284–1290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li F, Zhang J, Arfuso F, Chinnathambi A,
Zayed ME, Alharbi SA, Kumar AP, Ahn KS and Sethi G: NF-κB in cancer
therapy. Arch Toxicol. 89:711–731. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makin G and Hickman JA: Apoptosis and
cancer chemotherapy. Cell Tissue Res. 301:143–152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dandekar DS, Lopez M, Carey RI and
Lokeshwar BL: Cyclooxygenase-2 inhibitor celecoxib augments
chemotherapeutic drug-induced apoptosis by enhancing activation of
caspase-3 and −9 in prostate cancer cells. Int J Cancer.
115:484–492. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: Apoptosis: Mechanisms and relevance in cancer. Ann
Hematol. 84:627–639. 2005. View Article : Google Scholar : PubMed/NCBI
|
